Novel Recruitment, Data Collection, and Safety Reporting Methods in the Era of <scp>COVID</scp> ‐19: Design of a Post‐Emergency Use Authorization <scp>COVID</scp> ‐19 Vaccination Safety‐Surveillance Study

Cherise Wong, Katherine Kendrick, Laura Webb, Lauren Cohen, M. Patricia McAdams, Heather Rubino, Patrick Caubel, Emily O'Brien

Open source

DOI
10.1002/pds.70431
Published
2026-07
Container
Pharmacoepidemiology and Drug Safety
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/pds.70431,
  title = {Novel Recruitment, Data Collection, and Safety Reporting Methods in the Era of
                    <scp>COVID</scp>
                    ‐19: Design of a Post‐Emergency Use Authorization
                    <scp>COVID</scp>
                    ‐19 Vaccination Safety‐Surveillance Study},
  author = {Cherise Wong and Katherine Kendrick and Laura Webb and Lauren Cohen and M. Patricia McAdams and Heather Rubino and Patrick Caubel and Emily O'Brien},
  year = {2026},
  journal = {Pharmacoepidemiology and Drug Safety},
  doi = {10.1002/pds.70431},
  url = {https://doi.org/10.1002/pds.70431}
}

RIS

TY  - JOUR
TI  - Novel Recruitment, Data Collection, and Safety Reporting Methods in the Era of
                    <scp>COVID</scp>
                    ‐19: Design of a Post‐Emergency Use Authorization
                    <scp>COVID</scp>
                    ‐19 Vaccination Safety‐Surveillance Study
AU  - Cherise Wong
AU  - Katherine Kendrick
AU  - Laura Webb
AU  - Lauren Cohen
AU  - M. Patricia McAdams
AU  - Heather Rubino
AU  - Patrick Caubel
AU  - Emily O'Brien
PY  - 2026
JO  - Pharmacoepidemiology and Drug Safety
DO  - 10.1002/pds.70431
UR  - https://doi.org/10.1002/pds.70431
ER  - 

APA

Wong, C., Kendrick, K., Webb, L., Cohen, L., McAdams, M. P., Rubino, H., Caubel, P., & O'Brien, E. (2026). Novel Recruitment, Data Collection, and Safety Reporting Methods in the Era of <scp>COVID</scp> ‐19: Design of a Post‐Emergency Use Authorization <scp>COVID</scp> ‐19 Vaccination Safety‐Surveillance Study. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70431

Source records